Published on
October 12, 2022
- 21:10 GMT
New FDA-approved drug effectively targets prostate cancer cells, says acclaimed author and oncologist Dr. Mark Scholz
Drug attacks cancer while sparing normal cells LOS ANGELES, CA, UNITED STATES, October 12, 2022 /EINPresswire.com/ -- A “novel new way” of treating prostate cancer lets patients live longer and increases their quality of life, all with fewer and less …
Distribution channels:
Book Publishing Industry, Chemical Industry
...
